PharmaNest Founder and CEO Mathieu Petitjean and Global LIver Institute Vice President of Liver Programs Jeff McIntyre join Roger Green for 1:1 interviews exploring their key takeaways and strategic shifts resulting from the EASL Congress 2024, followed by a review of answers to a previous Question of the Week.
Roger Green speaks with Fatty Liver Alliance Founder and CEO Mike Betel on the day before the EASL Congress officially opens. The discussion includes sessions Mike attended and one he co-chaired with Shira Zelber-Sagi, which is covered in Season 5 Episode 23.
Four panelists from the EASL Congress session on “Patient Experiences in Clinical Settings” join Louise Campbell to how socioeconomic and psychological issues can affect the physician-patient dialogue.
Louise Campbell leads a discussion about challenges in provider-patient communication with Shira Zelber-Sagi and Mike Betel, who chaired a session on this topic at the EASL Congress 2024, and Tom Marjot and Jose Willemse, who were panelists for the discussion.
Jeff Lazarus and the Surfers discuss the upcoming UN event for “Healthy Livers, Healthy Lives,” focusing on MASLD awareness. They explore challenges in educating policymakers, strategies for highlighting MASLD’s impact, and ways listeners can support the initiative.
Healthy Livers, Healthy Lives Chair Jeff Lazarus and the Surfers discuss the value of the updated EASL/EASD/EASO MASLD clinical practice guidelines and explore the role of Big Data in early MASLD screening.
In this closing conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi and podcast co-hosts Louise Campbell and Roger Green consider what the guidelines might foretell in changes in provider education, structure of patient visits and treatment in less affluent or medically advanced countries.
For most of this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss key issues related to pharmacology and prescribing choices. At the end, the focus shifts to the guidelines’ overall benefits and some new kinds of education they call for.
In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss some of the guidelines’ key goals and issues surrounding the screening, diagnosis and management of MASLD patients.
In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi explain how the guidelines process benefitted from the close collaboration between EASL, EASD, and EASO.
